Major Gift Focuses Efforts on a Rare, but Devastating, Genetic Eye Disease
Nixon Foundation funds effort to study and treat macular dystrophy at Shiley Eye Institute. Currently, there are no effective treatments to slow or prevent genetic condition.
Nixon Foundation funds effort to study and treat macular dystrophy at Shiley Eye Institute. Currently, there are no effective treatments to slow or prevent genetic condition.
Few places in the country are better equipped to detect new virus variants than San Diego, where researchers at UC San Diego School of Medicine and Scripps Research, working with county public health officials, health systems and others, collaborate to create a sort of viral early warning system.
No one knew for sure what 2021 would be like. While the promise of vaccines loomed large at the end of last year, there were still many unknowns and challenges to face both within and outside the realm of public health. All we could do is forge ahead, continuing to do what we do best.
Pediatric ophthalmologist with Shiley Eye Institute at UC San Diego Health explains why infantile cataracts are more common — and problematic — than most people realize.
UC San Diego researchers identify new strategy to improve efficacy of immunotherapy on resistant liver cancers.
UC San Diego School of Medicine partners with The Michael J. Fox Foundation on a clinical study to identify biomarkers of Parkinson’s disease. The study seeks to recruit 4,000 participants by the end of 2023.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.